Soc. Generale Call 130 KINV/B 20..../ DE000SW9PTT0 /
31/05/2024 10:01:13 | Chg.+0.020 | Bid22:00:37 | Demandez à22:00:37 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.150EUR | +15.38% | - Bid taille: - |
- Ask la taille: - |
Kinnevik AB ser. B | 130.00 SEK | 20/09/2024 | Call |
GlobeNewswire
23:07
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
18:30
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
17:31
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
16:55
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
16:00
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
16:00
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
16:00
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
15:51
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
15:01
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
14:56
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
14:52
NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autono...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page